. 2022 Aug 11;23(1):99. doi: 10.1186/s10194-022-01466-0

Table 1.

Diary variables in the study phases for patients and controls

		Interictal photophobia		Ictal photophobia		Headache frequency		Headache severity
		Mean (SD)	P-value (FDR-corr.)^a	Mean (SD)	P-value (FDR-corr.)^a	Mean (SD)	P-value (FDR-corr.)^a	Mean (SD)	P-value (FDR-corr.)^a
Baseline	Patients (N = 10)	2.59 (1.82)	0.002	2.85 (2.85)	0.012	0.12 (0.09)	0.025	1.15 (0.88)	0.023
	Controls (N = 10)	0.06 (0.18)		0.00 (0.00)		0.01 (0.05)		0.00 (0.00)
	Total (N = 20)	1.32 (1.81)		1.43 (2.45)		0.07 (0.09)		0.58 (0.85)
Flash	Patients (N = 10)	2.53^b (1.50)	0.002	2.02 (2.56)	0.079	0.24 (0.31)	0.190	0.71 (0.78)	0.247
	Controls (N = 10)	0.01 (0.05)		0.00 (0.00)		0.06 (0.14)		0.23 (0.50)
	Total (N = 20)	1.27 (1.65)		1.01 (2.04)		0.15 (0.25)		0.47 (0.68)
Post Flash	Patients (N = 10)	1.67 (1.06)	0.002	2.75 (2.42)	0.012	0.18 (0.12)	0.013	1.45 (0.96)	0.023
	Controls (N = 10)	0.00 (0.00)		0.00 (0.00)		0.02 (0.05)		0.20 (0.63)
	Total (N = 20)	0.83 (1.12)		1.38 (2.18)		0.10 (0.12)		0.83 (1.02)
Dark	Patients (N = 10)	1.73 (1.47)	0.007	3.11 (2.39)	0.012	0.30 (0.26)	0.013	1.21 (0.71)	0.025
	Controls (N = 10)	0.00 (0.00)		0.00 (0.00)		0.01 (0.05)		0.20 (0.63)
	Total (N = 20)	0.86 (1.34)		1.56 (2.29)		0.16 (0.23)		0.70 (0.83)
Post Dark	Patients (N = 10)	1.55^b (1.47)	0.089	2.48 (3.01)	0.003	0.21 (0.23)	0.111	1.10 (1.07)	0.247
	Controls (N = 10)	0.00 (0.00)		0.10 (0.32)		0.04 (0.07)		0.50 (0.85)
	Total (N = 20)	0.78 (1.28)		1.29 (2.41)		0.12 (0.18)		0.80 (0.99)

^aGroup comparisons using Quade analysis of covariance (adjusted for multiple comparisons using false discovery rate (FDR))

^bSignificant post-hoc comparisons between study phases (FDR-corr.)